Objectives: To test whether dexamethasone (DEX) treatment in pregnancies at risk for congenital adrenal hyperplasia (CAH) impairs cognitive functioning in the offspring. Design: Observational follow-up of prenatally DEX-exposed offspring and controls. Methods: Study 1 included 140 children aged 5-12 years: 67 DEX-exposed (long-term: eight CAH girls) and 73 unexposed (with 15 CAH girls). Study 2 included 20 participants aged 11-24 years: seven DEX-exposed (long-term: one CAH woman) and 13 unexposed (with four CAH women). Neuropsychological testing was done in hospital settings or at patients' homes. Data analysis aimed at maximizing detection of the effects of DEX exposure. Results: The vast majority of group comparisons were not marginally or conventionally significant. The few significant findings on short-term prenatal DEX exposure suggested more positive than adverse outcomes. By contrast, few significant findings in females with CAH and long-term DEX exposure indicated slower mental processing than in controls on several neuropsychological variables, although partial correlations of DEX exposure duration with cognitive outcome did not corroborate this association. Conclusions: Although our studies do not replicate a previously reported adverse effect of short-term prenatal DEX exposure on working memory, our findings on cognitive function in CAH girls with long-term DEX exposure contribute to concerns about potentially adverse cognitive after effects of such exposure. Yet, our studies are not definitive, and replications in larger samples are required.
Introduction 46,XX newborns affected by classical congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency show variable masculinization of the genitalia. They are, therefore, at increased risk of erroneous assignment to the male gender or, if assigned to the female gender, of feminizing genital surgery with its attendant risks to later sexual functioning (1, 2) . To prevent these sequelae of the CAH condition, dexamethasone (DEX) treatment in CAH-risk pregnancies was introduced in 1978 by Forest in France and in 1986 by New in the USA (3, 4) . The treatment has indeed been shown to be highly efficacious in reducing genital masculinization in 46,XX fetuses, if begun by the 8th week postconception and used consistently throughout pregnancy (5, 6 ). Yet, this approach to prevention has become increasingly controversial because animal studies on the effects of fetal exposure to high-dose DEX suggest potentially adverse side effects on brain development and, especially, memory function, along with 'programming' of the hypothalamic-pituitary-adrenal axis (HPAA) involving potentially long-term adverse effects on blood pressure, glucose regulation, and other functions (5, 7, 8) ; shortterm HPAA effects have also been shown in humans (9) . An additional concern is the fact that for DEX treatment to be effective it has to begin before the sex and CAH diagnosis of the fetus can be established with current ascertainment methods. This implies that the treatment is not limited to 46,XX fetuses with definitive diagnosis of classical 21-OHD CAH. It also exposes to DEX CAH-affected 46,XY fetuses and CAH-unaffected fetuses of both sexes, until fetal sex and CAH status can be determined either via amniocentesis (as of gestational weeks [15] [16] [17] [18] or via chorionic villus sampling (as of gestational weeks [10] [11] [12] . Thus, in such cases, the relatively short-term exposure to DEX may still carry risks without providing any benefits. The use of cell-free fetal Y-chromosomal DNA in maternal plasma as a new noninvasive technique for fetal sex determination early in pregnancy may now allow the exclusion of males from this treatment altogether (5), but it was not available for the samples described here.
Recent reviews have summarized a few and as yet unreplicated pertinent findings concerning potential adverse psychological side effects in prenatally DEXexposed offspring from a few small-scale psychological follow-up studies available on humans (5, 6 ). An early pilot study from our team showed increased shyness and inhibition in DEX-exposed children (10) , but a larger follow-up study using several parent-administered, standardized developmental questionnaires on 174 prenatally DEX-exposed children (including 48 with CAH) and 313 unexposed children (including 195 with CAH) did not show any effects of short-term or long-term prenatal DEX exposure on standard scales of motor, cognitive, and social development (11) . More recently, a Swedish study by Hirvikoski et al. compared 26 DEXexposed children aged 7-17 years (four girls with CAH, five boys with CAH, seven non-CAH boys, and ten non-CAH girls) with 35 non-CAH controls (15 boys and 20 girls) matched for age and sex, by direct examination of children by neuropsychological tests. The authors found no effects of prenatal DEX exposure on intelligence, handedness, memory encoding, or long-term memory, but among the short-term-treated, CAH-unaffected children had significantly poorer performance than controls on a test of verbal working memory as well as lower questionnaire scores on self-perceived scholastic competence and increased social anxiety (12) . The parents described these children as more sociable than controls, and there were no significant differences in psychopathology, behavioral problems, adaptive functioning, parents' reports of 'any academic or other problems in school', or placement in a special class/special school (13) .
The current report focuses exclusively on cognitive functioning in offspring from DEX-exposed pregnancies and controls. If early-onset prenatal DEX exposure has indeed adverse effects on the developing brain in humans as deduced from the animal data, one could expect impairments of specific cognitive functions, such as working memory, as well as of even broader indicators, such as intelligence or educational attainment. Here, we will report findings from two neuropsychological follow-up studies on DEX-exposed offspring and controls: Study 1 on 5-to 12-year-old children and Study 2 on a small feasibility sample of adolescents and adults.
Subjects and methods

Study population
Study 1 was conducted as one of several USA-wide follow-up studies on offspring from DEX-treated CAH-risk pregnancies. The main source of participating children was the prenatal diagnosis database of one of the authors (M I New), which included prenatally DEX-exposed and DEX-unexposed boys and girls with and without CAH (4), all from families with at least one CAH-affected index case (sibling, parent, or close relative). The DEX treatment itself had been under the care of the mother's local obstetrician/gynecologist. Additional unexposed CAH children came from the same author's database for other medical CAH studies. Following our preceding questionnaire study of the cognitive and motor development of prenatally DEX-exposed children from infancy to 12 years of age in a USA-wide sample (11), we conducted a comprehensive face-to-face investigation of behavioral aftereffects of prenatal DEX exposure in 140 children aged 5-12 years (for gender identity-related findings from that study, see (14) ). Because of funding limits, only a part sample of the eligible children evaluated in the preceding study could be tested in the current project. Apart from requiring a minimum age of 5 years, the major selection criterion was parental consent (during the data collection period from June 1998 to November 2000) either to the family's evaluation visit in the senior author's (M I New) hospital setting in New York City or to the study team's evaluation visit in the family's hometown. For the latter option, we favored geographical areas with several families that were able to participate, in order to minimize the travel expenses of our team. Among the children without CAH, we selected more females than males in order to increase the statistical power of comparisons for subtle DEX effects, if any, on (androgen-influenced) gender behavior in females (a topic not covered in the current paper). We also aimed at achieving a balanced distribution between DEX-exposed and DEX-unexposed children.
The final sample included 140 children aged 5-12 years: 67 with DEX exposure (long-term: eight CAH girls (seven with the salt-wasting (SW) variant and one with the simple-virilizing (SV) variant); short-term: eight CAH boys (seven SW and one SV), 35 non-CAH girls, and 16 non-CAH boys) and 73 unexposed (15 CAH girls (13 SW and two SV), 11 CAH boys (ten SW and one SV), 31 non-CAH girls, and 16 non-CAH boys). In terms of ethnicity, 130 children were white, six Hispanic, two African-American, one Asian, and one other. We were able to obtain the start and end date of DEX treatment for 65 of the 67 DEX-exposed children (it was unavailable for one boy with CAH and one non-CAH girl). Although in principle 46,XX fetuses with CAH should be DEX treated throughout pregnancy and the others only for short periods in early pregnancy, the calculated duration of actual DEX exposure was quite variable, depending on maternal access to and compliance with DEX treatment during pregnancy: the two lowest duration scores in girls with CAH were 9 and 19 weeks, and the seven longest duration scores among the non-CAH children ranged from 23 to 39 weeks. Nevertheless, as the mean and median of DEX duration for the DEX-exposed girls with CAH are significantly and very markedly higher than those of the other DEX-exposed subgroups, we will use the denotation 'long-term' for the DEX exposure of girls with CAH and 'short-term' for the DEX exposure of the other subgroups throughout this article. Mean midparental education (15) was 5.50 (between at least 1 year of college or specialized training, and standard college or university graduation, but not a graduate degree); the lowest score was 3.5 (just below high school graduate), which applied to nine children. Thus, in comparison with national norms, the sample was somewhat elevated in socioeconomic level. For subjects and methods of Study 2, see Supplementary Study (see section on supplementary data given at the end of this article).
Procedures
The face-to-face evaluations took place either in an office of the senior author's (M I New) department or in a suitable room of the family's home or a nearby hotel. Written informed consent was obtained from all participating mothers and assent from the older children, after the appropriate institutional review boards had approved the study. Participants received $100 per family for their study participation, and families traveling to New York city were reimbursed for their travel expenses.
Assessments
Neuropsychological tests were done as part of a comprehensive assessment protocol involving semistructured interviews and systematic play observations with the child and a demographic interview with a parent. The tests were done early in the sequence of procedures in order to minimize the child's fatigue. Cognitive development was assessed with the Kaufman Assessment Battery for Children (K-ABC) (16, 17) and the Wide Range Assessment of Memory and Learning (WRAML) (18) . The K-ABC is an intelligence test that includes three global scales of problem solving and information processing, Sequential Processing (including short-term memory tasks that require immediate recall of visual or auditory stimuli), Simultaneous Processing (with subtests composed of visual spatial stimuli), and Mental Processing Composite (a combination of the other two), and one global scale of acquired factual knowledge, Achievement (including measures of reading skills and other subtests that require verbal responses to either pictures or questions). The WRAML provides four 'learning indexes': Verbal Memory (use of language in memory tasks that vary in semantic complexity), Visual Memory (visual memory tasks that vary in meaningfulness), Learning (performance over repeated trials), and General Memory (composite of the first three scales). Both the K-ABC global scales and the WRAML indexes are expressed as standardized age-based norm scores with a population mean of 100 and a S.D. of 15. The subtests of the K-ABC Mental Processing Scales provide a scaled score with a mean of 10 and a S.D. of 3; the K-ABC Achievement subtests yield scaled scores with a mean of 100 and a S.D. of 15. The testing was performed by research assistants with a bachelor degree in psychology, who were trained in the administration of the study tests by a collaborating neuropsychologist (R Haggerty), and their performance was monitored by the study coordinator, a doctorate-level senior clinical psychologist. These research assistants did not participate in the recruitment procedures and did not know the CAH and DEX exposure status of the children they tested.
Data analysis
To maximize our chances of detecting adverse effects of DEX treatment, we used four approaches: i) DEXexposed and DEX-unexposed participants were compared based on neuropsychological test scores by independent samples t-tests. t-tests and Cohen's d (using pooled variances) were performed separately for girls with CAH, girls without CAH, boys with CAH, and boys without CAH, as well as for non-CAH girls and boys combined. (As two of the K-ABC subtests, Photo Series and Reading/Understanding, are not applicable to our youngest age groups, the respective subsample sizes are reduced, as listed in Supplementary Table 1 , see section on supplementary data given at the end of this article.) Age and midparental education were considered as covariates in these analyses but not included because no significant differences were found between any comparison groups, and the test scores were age-based norm scores. ii) Hierarchical regression analyses were performed separately for boys and girls. Both DEX (yes/no) and CAH (yes/no) were included in the initial regression model to assess the main effect of DEX treatment, controlling for CAH status. The DEX by CAH (DEX!CAH) interaction was then added to the regression model to test whether neuropsychological performance was associated with DEX treatment differently between CAH and non-CAH participants. iii) Because of the variability of DEX exposure duration, we performed partial correlations to test for an association between neuropsychological scores and the duration of DEX treatment (in weeks). Initial correlations included all DEX-treated participants and adjusted for CAH status (non-affected, 0; affected, 1) and gender (boy, 1; girl, 2). Additional correlations were performed separately for CAH and non-CAH participants, adjusting for gender. iv) Finally, as in the Swedish study (12) , all three sets of analyses, except those with Achievement and its subtests as outcomes, were redone as regression analyses adjusting for intelligence quotient (IQ; operationalized as K-ABC Achievement) to test whether controlling for IQ noticeably affected the results.
Statistical analyses were conducted using SPSS for Windows release 18.0.0. In line with our detection focus, we report both marginal (P%0.10) and conventional (P%0.05) significance levels without adjustment for multiple comparisons.
Outcome after prenatal dexamethasone
Results
In regard to Study 1, Table 1 presents the mean and S.D. of age, midparental education, and the major neuropsychological outcome variables as well as their effect sizes for the DEX-exposed vs the DEX-unexposed separately for girls with CAH, girls without CAH, boys with CAH, and boys without CAH. Only three of the 40 t-tests on neuropsychological test variables reached marginal significance (0.05!P%0.10) and none reached conventional significance (P%0.05). Girls with CAH and long DEX exposure performed (marginally) more poorly on the K-ABC Mental Processing Composite. Non-CAH boys with short-term DEX exposure performed (marginally) better on K-ABC Sequential Processing, and the same held true for non-CAH boys and girls combined.
Of the 16 hierarchical regression analyses, nine reached one or more results of (marginal or conventional) statistical significance. For girls, analyses of the K-ABC global scores yielded no main effects for DEX treatment but marginal effects for CAH (girls with CAH scoring lower than non-CAH) and conventionally significant (P%0.05) CAH!DEX interactions on two K-ABC variables, Sequential Processing and the Mental Processing Composite (which includes the former variable). These interactions indicate that among the CAH-affected girls, the (long-term) DEX-exposed ones scored lower (worse) than the unexposed, while among the non-CAH girls, the (short-term) DEX-exposed ones scored higher (better) than the unexposed. Analyses of the WRAML indexes yielded neither any significant main effects nor any significant interaction effects.
For boys, analyses of the K-ABC global scores showed no main effects for CAH and no significant CAH!DEX interactions. However, the main effects for DEX were marginally significant (P%0.10) for the three variables: Sequential Processing, Mental Processing Composite (which includes the former), and Achievement; the mean scores for prenatally (short-term) DEX-exposed boys were higher (better) than those for the unexposed. None of the analyses of the WRAML indexes for boys reached marginal or conventional significance.
Of the 24 partial correlations for global test variables within DEX-exposed children (not shown), only one reached conventional significance. Among non-CAH children, DEX treatment duration correlated positively (r p Z0.33; dfZ47; PZ0.020) with WRAML Visual Memory. Two correlations were marginal: DEX treatment duration correlated positively with WRAML Visual Memory (r p Z0.24; dfZ61; PZ0.063) for the total sample and WRAML General Memory Index (r p Z0.27; dfZ47; PZ0.059) for the non-CAH children.
Supplementary Table 1 (see section on supplementary data given at the end of this article) presents the respective data for the 13 individual K-ABC subtests that apply to the age group examined in this study, arranged by their respective global score categories: Sequential Processing, Simultaneous Processing, and Achievement. Only nine of the 65 t-tests on K-ABC subtests reached marginal or conventional significance. Girls with CAH and (long-term) DEX exposure performed (marginally) less well on Hand Movements (a subtest for Sequential Processing) and Spatial Memory (Simultaneous Processing). Non-CAH girls with (shortterm) DEX exposure performed significantly less well on Faces & Places (a subtest of Achievement). Boys with CAH did not show an effect of (short-term) DEX exposure. Non-CAH boys with (short-term) DEX exposure performed significantly better than DEX-unexposed boys on Number Recall and Word Order (both subtests of Sequential Processing) and marginally better on Reading/Decoding and Reading/Understanding. Non-CAH boys and girls combined with (short-term) DEX exposure performed significantly better than the unexposed on Number Recall and marginally better on Word Order.
Of the 13 hierarchical regression analyses for girls, six variables showed results of conventional or marginal significance; two of these were Sequential Processing subtests, three Simultaneous Processing subtests, and one an Achievement subtest. CAH girls as a group performed less well than non-CAH girls on Triangles (conventional significance), Word Order (marginal significance), and Photo Series (conventional significance). CAH!DEX interactions reached marginal significance on three variables and conventional significance on one. On Hand Movements and Spatial Memory, DEX-exposed CAH girls performed less well than DEX-unexposed CAH girls, while DEX-exposed non-CAH girls performed slightly better than DEX-unexposed non-CAH girls. The reverse pattern emerged on Faces & Places. No main effects for DEX exposure became significant.
Of the 13 hierarchical regression analyses for boys, five variables showed results of conventional or marginal significance; two of these were Sequential Processing subtests, one a Simultaneous Processing subtest, and two Achievement subtests. On Number Recall, CAH boys performed less well than non-CAH boys, and all five variables (Number Recall, Word Order, Photo Series, Reading/Decoding, and Reading/ Understanding) showed better performance in boys with DEX exposure. None of the CAH!DEX interactions reached significance.
Of the 39 partial correlations for the K-ABC subtests (not shown in Supplementary Table 1, see section on supplementary data given at the end of this article), three were conventionally significant. DEX treatment duration correlated positively with Faces & Places for the total sample (r p Z0.29; dfZ61; PZ0.022) as well as for non-CAH children (r p Z0.30; dfZ47; PZ0.037) and negatively with Reading/Understanding for CAH children (r p Z0.87; dfZ5; PZ0.011), but the small sample size of the latter raises doubts in its utility. Re-analysis of the data with adjustment for K-ABC Achievement as IQ estimate yielded slight increases in P values and, thereby, reduction of the number of (marginally or conventionally) significant variables by nine and, conversely, slight decreases in P values and, thereby, the addition of five newly (marginally or conventionally) significant variables, but did not affect the overall conclusions (not shown). For results of Study 2, see Supplementary Study and Table 2 (see section on supplementary data given at the end of this article).
Discussion
The vast majority of group comparisons in Study 1 ( Table 1 and Supplementary Table 1 , see section on supplementary data given at the end of this article) were not significant, neither conventionally nor marginally. Thus, our data do not indicate a strong broadband effect of early-onset prenatal DEX exposure on mental processing and memory performance in childhood. However, the pattern of few significant findings suggests a difference in effect between short-and long-term exposures during pregnancy. Except for one conventionally significant result, most findings for short-term exposure (five marginally and three conventionally significant) show better performance for the DEX exposed compared with controls, while the long-term findings (three marginally significant) show worse performance for the DEX exposed. This contrast is further strengthened by the results of the hierarchical regression analyses and even maintained -albeit weakened -when adjusted for IQ. The small data set from Study 2 shows a similar pattern.
Thus, if there is indeed a replicable adverse effect of early-onset prenatal DEX exposure, it appears to be more likely with long-term exposure. Our data suggest that the K-ABC measures of both sequential and simultaneous processing may be particularly sensitive to longterm DEX exposure. On the other hand, the positive partial correlations of cognitive data with DEX exposure duration in Study 1 (two in the total sample, namely, WRAML Visual Memory and K-ABC Faces & Places, and three in the non-CAH sample, namely, WRAML Visual Memory, WRAML General Memory Index, and K-ABC Faces & Places; of those five, three marginally and two conventionally significant) do not support an adverse effect of DEX exposure on the neuropsychological variables assessed here. The one negative correlation, with K-ABC Reading/Understanding, in the subsample with CAH includes only five patients and is therefore hardly interpretable. This finding, along with the low statistical power of our long-term exposure comparisons, indicates that, while raising concerns, our findings on long-term prenatal DEX exposure are not definitive.
Despite selecting a battery of tests emphasizing mental processing and memory performance, we did not corroborate the findings by Hirvikoski et al. (12) of adverse effects of short-term prenatal DEX exposure on memory. Several explanations appear plausible. i) Short-term prenatal DEX affects only the specific working memory ability covered by the Wechsler Digit Span test, i.e. both forward and backward digit recall, not just the working memory's short-term memory component involved in forward digit span. This would be a very narrow impairment indeed, but this possibility cannot be currently excluded. On the other hand, one needs to keep in mind that Wechsler Digit Span is an incomplete measure of working memory as currently conceptualized (23, 24) ; only a battery of experimental procedures can comprehensively assess all its individual components. ii) In the US health care system, DEX treatment of CAH-risk pregnancies implies a positive socioeconomic bias associated with cognitive ability or educational level favoring the DEX exposed over controls. However, such a selection bias is not indicated by the data on midparental education and IQ in Study 1 (but may play a role in the very small Study 2). iii) Among males with CAH, prenatal diagnosis and prenatal DEX treatment usually imply immediate postnatal initiation of glucocorticoid and mineralocorticoid treatment, as appropriate, while in the control males with CAH, the diagnosis at birth and start of treatment are more likely delayed with the attendant risks of electrolyte crises and their potentially adverse effects on the developing brain (2, 25, 26, 27 ) (of course, even in prenatally diagnosed and treated children with CAH, postnatal electrolyte crises may occur due to lapses in treatment adherence or failure to increase the medication dose during illness). In any case, this rationale does not apply to the non-CAH groups. iv) The least plausible explanation is that shortterm prenatal DEX exposure actually improves cognitive outcome. We are not aware of an evidence-based rationale that would support such a hypothesis.
Our follow-up studies have two significant limitations, as is typical of all studies to date in this area. One is that DEX treatment was not prescribed in the format of a randomized clinical trial. Instead, we conducted an observational follow-up study of a clinical treatment sample and, in Study 1, could rule out a decisive influence of the most obvious potentially confounding variables: age, midparental education, and IQ. The other significant limitation is that, because of financial constraints, only a part of the total DEXexposed sample could be included. This fact limited the sample size and thereby the statistical power of the group comparisons. It is not clear, however, whether it led to any biases in our findings.
In conclusion, our studies do not replicate an earlier report of adverse effects of short-term prenatal DEX exposure on working memory, while our finding of lower cognitive processing in CAH girls and women with long-term DEX exposure contributes to concerns about potentially adverse cognitive after effects of such
